Participation of critical residues from the extreme C-terminal end of the human androgen receptor in the ligand binding function

被引:20
作者
Tahiri, B [1 ]
Auzou, G [1 ]
Nicolas, JC [1 ]
Sultan, C [1 ]
Lupo, B [1 ]
机构
[1] INSERM, U439, F-34090 Montpellier, France
关键词
D O I
10.1021/bi010146q
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A Short C-terminal end is present at the end of the human androgen receptor (hAR) similar to that of other steroid receptors. It is located directly after helix 12 of the ligand binding domain and has never been described as being part of the hydrophobic binding pocket. Although some fragmentary data have indicated the involvement of this region in ligand binding, its precise function still remains unclear. To gain deeper insight into the role of the hAR extreme C-terminal end, an extensive mutational analysis was carried out by using site-directed mutagenesis and alanine scanning over the 13-residue C-terminal end region. Both ligand binding and transcriptional activity were tested with each mutant. Our study demonstrates the participation of almost all of the amino acids in this region for the ligand binding function and consequently for the transcriptional activity. A conformational study by limited proteolysis was performed with the mutants that most affected the affinity of the receptor. It was remarkable that the mutants with a low binding affinity adopted an inactive conformation and were either less or not able to undergo a following conformational change to provide the active form of the receptor. Our results demonstrate the importance of hydrophobicity for the function of the C-terminal end with residues located at very precise positions. Especially, both hydrophobicity and aromaticity on position 916 are critical for providing the correct ligand binding conformation of the receptor. Furthermore, this study highlights essential criteria regarding the C-terminal amino acids which could be applied to other steroid receptors.
引用
收藏
页码:8431 / 8437
页数:7
相关论文
共 37 条
[1]   Wide variation in androgen receptor dysfunction in complete androgen insensitivity syndrome [J].
Bevan, CL ;
Hughes, IA ;
Patterson, MN .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1997, 61 (1-2) :19-26
[2]   CRYSTAL-STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE HUMAN NUCLEAR RECEPTOR RXR-ALPHA [J].
BOURGUET, W ;
RUFF, M ;
CHAMBON, P ;
GRONEMEYER, H ;
MORAS, D .
NATURE, 1995, 375 (6530) :377-382
[3]   Mechanisms of androgen receptor activation and function [J].
Brinkmann, AO ;
Blok, LJ ;
de Ruiter, PE ;
Doesburg, P ;
Steketee, K ;
Berrevoets, CA ;
Trapman, J .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1999, 69 (1-6) :307-313
[4]   Molecular basis of agonism and antagonism in the oestrogen receptor [J].
Brzozowski, AM ;
Pike, ACW ;
Dauter, Z ;
Hubbard, RE ;
Bonn, T ;
Engstrom, O ;
Ohman, L ;
Greene, GL ;
Gustafsson, JA ;
Carlquist, M .
NATURE, 1997, 389 (6652) :753-758
[5]   PHENYLALANINE-780 NEAR THE C-TERMINUS OF THE MOUSE GLUCOCORTICOID RECEPTOR IS IMPORTANT FOR LIGAND-BINDING AFFINITY AND SPECIFICITY [J].
CHEN, DG ;
KOHLI, K ;
ZHANG, SM ;
DANIELSEN, M ;
STALLCUP, MR .
MOLECULAR ENDOCRINOLOGY, 1994, 8 (04) :422-430
[6]   RAR-SPECIFIC AGONIST/ANTAGONISTS WHICH DISSOCIATE TRANSACTIVATION AND AP1 TRANSREPRESSION INHIBIT ANCHORAGE-INDEPENDENT CELL-PROLIFERATION [J].
CHEN, JY ;
PENCO, S ;
OSTROWSKI, J ;
BALAGUER, P ;
PONS, M ;
STARRETT, JE ;
RECZEK, P ;
CHAMBON, P ;
GRONEMEYER, H .
EMBO JOURNAL, 1995, 14 (06) :1187-1197
[7]   Partial androgen insensitivity caused by an androgen receptor mutation at amino acid 907 (Gly->Arg) that results in decreased ligand binding affinity and reduced androgen receptor messenger ribonucleic acid levels [J].
Choong, CS ;
Strum, MJ ;
Strophair, JA ;
McCulloch, RK ;
Tilley, WD ;
Leedman, PJ ;
Hurley, DM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (01) :236-243
[8]   Folding requirements of the ligand-binding domain of the human mineralocorticoid receptor [J].
Couette, B ;
Jalaguier, S ;
Hellal-Levy, C ;
Lupo, B ;
Fagart, J ;
Auzou, G ;
Rafestin-Oblin, ME .
MOLECULAR ENDOCRINOLOGY, 1998, 12 (06) :855-863
[9]   Cation-π interactions in structural biology [J].
Gallivan, JP ;
Dougherty, DA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (17) :9459-9464
[10]  
*GHIRR BROWN, 1993, PAEDIAT RES S, V33, P95